News
MHRA bans valproate prescribing for women not in pregnancy prevention programme
BMJ 2018; 361 doi: https://doi.org/10.1136/bmj.k1823 (Published 25 April 2018) Cite this as: BMJ 2018;361:k1823
- Gareth Iacobucci
- The BMJ
The Medicines and Healthcare Products Regulatory Agency (MHRA) has banned the antiepileptic drug sodium valproate in the UK in all women of childbearing potential who are not enrolled in a pregnancy prevention programme.
The regulator said that it had made the decision to protect public health and in close collaboration with professional bodies, NHS organisations, and patient and campaign groups.1
Women or girls who are already taking valproate should consult their GP to have their …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.